Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)
Study Number: GI008
This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon cancer.
- Navigator Carrie, 309-243-3621 firstname.lastname@example.org
- Drea, 309-243-3626 email@example.com